prednisolone has been researched along with Complex Regional Pain Syndrome in 6 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Excerpt | Relevance | Reference |
---|---|---|
"Articles published from January 1, 1980 to July 23, 2021 in the PubMed database were searched using the following key phrases: (prednisolone OR corticosteroid OR steroid) AND (complex regional pain syndrome OR reflex sympathetic dystrophy OR shoulder-hand syndrome OR causalgia)." | 9.22 | Effectiveness of prednisolone in complex regional pain syndrome treatment: A systematic narrative review. ( Chang, MC; Choo, YJ; Kwak, SG, 2022) |
"To compare the effect of prednisolone with that of piroxicam in patients with CRPSI following stroke." | 9.12 | Comparison of prednisolone with piroxicam in complex regional pain syndrome following stroke: a randomized controlled trial. ( Kalita, J; Misra, UK; Vajpayee, A, 2006) |
"Since the degree of overexpression of D3R is increased in a high dose of pramipexole, for patients with PD who are treated with L-dopa chronically, a new use of pramipexole and an increase in dose to alleviate the symptoms of PD should be implemented with caution while closely observing the occurrence of drug-induced complications such as dystonia and CRPS." | 7.85 | Pramipexole-induced limb dystonia and its associated complex regional pain syndrome in idiopathic Parkinson's disease: A case report. ( Park, D, 2017) |
"Articles published from January 1, 1980 to July 23, 2021 in the PubMed database were searched using the following key phrases: (prednisolone OR corticosteroid OR steroid) AND (complex regional pain syndrome OR reflex sympathetic dystrophy OR shoulder-hand syndrome OR causalgia)." | 5.22 | Effectiveness of prednisolone in complex regional pain syndrome treatment: A systematic narrative review. ( Chang, MC; Choo, YJ; Kwak, SG, 2022) |
"To compare the effect of prednisolone with that of piroxicam in patients with CRPSI following stroke." | 5.12 | Comparison of prednisolone with piroxicam in complex regional pain syndrome following stroke: a randomized controlled trial. ( Kalita, J; Misra, UK; Vajpayee, A, 2006) |
"Since the degree of overexpression of D3R is increased in a high dose of pramipexole, for patients with PD who are treated with L-dopa chronically, a new use of pramipexole and an increase in dose to alleviate the symptoms of PD should be implemented with caution while closely observing the occurrence of drug-induced complications such as dystonia and CRPS." | 3.85 | Pramipexole-induced limb dystonia and its associated complex regional pain syndrome in idiopathic Parkinson's disease: A case report. ( Park, D, 2017) |
"The early phase of complex regional pain syndrome (CRPS) is characterized by an inflammatory state and therefore often treated with anti-inflammatory acting glucocorticoids." | 2.90 | Short-Term Glucocorticoid Treatment Normalizes the Microcirculatory Response to Remote Ischemic Conditioning in Early Complex Regional Pain Syndrome. ( Hegelmaier, T; Kolbenschlag, J; Kumowski, N; Maier, C; Mainka, T; Michel-Lauter, B, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Kwak, SG | 1 |
Choo, YJ | 1 |
Chang, MC | 1 |
Kalita, J | 2 |
Pandey, PC | 1 |
Shukla, R | 1 |
Misra, UK | 2 |
Park, D | 1 |
Kumowski, N | 1 |
Hegelmaier, T | 1 |
Kolbenschlag, J | 1 |
Mainka, T | 1 |
Michel-Lauter, B | 1 |
Maier, C | 1 |
Barbalinardo, S | 1 |
Loer, SA | 1 |
Goebel, A | 1 |
Perez, RS | 1 |
Vajpayee, A | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Physical and Psychological Changes in Complex Regional Pain Syndrome (CRPS) Patients Undergoing Multimodal Rehabilitation[NCT05696587] | 42 participants (Actual) | Interventional | 2021-10-10 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for prednisolone and Complex Regional Pain Syndrome
Article | Year |
---|---|
Effectiveness of prednisolone in complex regional pain syndrome treatment: A systematic narrative review.
Topics: Activities of Daily Living; Complex Regional Pain Syndromes; Humans; Observational Studies as Topic; | 2022 |
4 trials available for prednisolone and Complex Regional Pain Syndrome
Article | Year |
---|---|
Prednisolone 20 mg vs 40 mg in complex regional pain syndrome type I: A randomized controlled trial.
Topics: Complex Regional Pain Syndromes; Humans; Pain Measurement; Prednisolone; Reflex Sympathetic Dystroph | 2023 |
Short-Term Glucocorticoid Treatment Normalizes the Microcirculatory Response to Remote Ischemic Conditioning in Early Complex Regional Pain Syndrome.
Topics: Adult; Arm; Complex Regional Pain Syndromes; Female; Glucocorticoids; Humans; Ischemic Preconditioni | 2019 |
The Treatment of Longstanding Complex Regional Pain Syndrome with Oral Steroids.
Topics: Adult; Aged; Complex Regional Pain Syndromes; Drug Administration Schedule; Female; Glucocorticoids; | 2016 |
Comparison of prednisolone with piroxicam in complex regional pain syndrome following stroke: a randomized controlled trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Complex Regional Pain Syndromes; Female; Humans; Male; Middle | 2006 |
1 other study available for prednisolone and Complex Regional Pain Syndrome
Article | Year |
---|---|
Pramipexole-induced limb dystonia and its associated complex regional pain syndrome in idiopathic Parkinson's disease: A case report.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Complex Regional Pain Syndromes; Dystonia; Female; Foot; | 2017 |